Acarix — Investor Relations & Filings

Acarix is a medical device company focused on developing solutions for the rapid, non-invasive diagnosis of Coronary Artery Disease (CAD) at the point of care. Its primary product, the CADScor® System, is a diagnostic aid that uses AI-powered acoustic technology. The system analyzes coronary blood flow with a highly sensitive sensor and advanced computational processing to calculate a patient-specific CAD-score. This score, combined with risk factors, allows healthcare professionals to immediately stratify the risk of significant coronary stenosis in symptomatic patients. The radiation-free device is designed as a frontline tool to help rule out CAD, providing actionable results to improve diagnostic pathways. The CADScor® System has received both CE marking and FDA De Novo clearance.